We are international
Donate
TEXT SIZE   


ASCO 2012: Dr. Richardson - Oral weekly MLN9708, an investigational proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: A phase I/II study
Paul Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, USA
06.26.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles